Trial Profile
Effect of eculizumab in patients with atypical Hemolytic Uremic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Atypical Haemolytic Uraemic Syndrome
- Focus Therapeutic Use
- 21 Apr 2015 New trial record